Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John David Chetwood

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Alimentary Pharmacology & Therapeutics|September 19, 2024
Letter: Ulcerative proctitis-A step towards addressing the knowledge gap, and a call for greater detail, in trial dataJohn David Chetwood, Nik Sheng Ding
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 7, 2026
Subcutaneous Infliximab and Assumptions of Response in Ileal Crohn's Disease: Does Route of Administration Matter?John David Chetwood, Robert David Little
Alimentary Pharmacology & Therapeutics|January 2, 2025
Editorial: Where to Start in Ulcerative Colitis?Tanya Lee, Nik Ding, John David Chetwood
Simulation in Healthcare : Journal of the Society for Simulation in Healthcare|January 27, 2018
High-Fidelity Realistic Acute Medical Simulation and SBAR Training at a Tertiary Hospital in Blantyre, MalawiJohn David Chetwood, Priya Garg, Kieran Burton
The American Journal of Gastroenterology|January 9, 2025
Infliximab and Adalimumab in the Treatment of Fistulizing Crohn's Disease: A Propensity Score-Matched Analysis From the Prospective Persistence Australian National IBD Cohort (PANIC4) StudyJohn David Chetwood, Sudarshan Paramsothy, Rupert W Leong
Expert Review of Gastroenterology & Hepatology|February 23, 2019
Systematic review: the etiology of esophageal squamous cell carcinoma in low-income settingsJohn David Chetwood, Priya Garg, Peter Finch, et al.
Alimentary Pharmacology & Therapeutics|November 13, 2024
Letter: Bowel Preparation Quality in Patients With Crohn's DiseaseTamar Schildkraut, Nik John S Ding, John David Chetwood
Clinical Case Reports|August 21, 2024
Genital rash: A manifestation of metastatic Crohn's diseaseJohn David Chetwood, Arteen Arzivian, Joo-Shik Shin, et al.
Alimentary Pharmacology & Therapeutics|July 11, 2025
Meta-Analysis: Intravenous Versus Subcutaneous Infliximab in Inflammatory Bowel DiseaseJohn David Chetwood, Arteen Arzivian, Yvonne Tran, et al.
The American Journal of Gastroenterology|January 26, 2024
Biological Agents in the Treatment of Crohn's Disease: A Propensity Score-Matched Analysis From the Prospective Persistence Australian National IBD Cohort (PANIC3) StudyJohn David Chetwood, Yanna Ko, Aviv Pudipeddi, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Alimentary Pharmacology & Therapeutics|September 19, 2024
Letter: Ulcerative proctitis-A step towards addressing the knowledge gap, and a call for greater detail, in trial dataJohn David Chetwood, Nik Sheng Ding
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 7, 2026
Subcutaneous Infliximab and Assumptions of Response in Ileal Crohn's Disease: Does Route of Administration Matter?John David Chetwood, Robert David Little
Alimentary Pharmacology & Therapeutics|January 2, 2025
Editorial: Where to Start in Ulcerative Colitis?Tanya Lee, Nik Ding, John David Chetwood
Simulation in Healthcare : Journal of the Society for Simulation in Healthcare|January 27, 2018
High-Fidelity Realistic Acute Medical Simulation and SBAR Training at a Tertiary Hospital in Blantyre, MalawiJohn David Chetwood, Priya Garg, Kieran Burton
The American Journal of Gastroenterology|January 9, 2025
Infliximab and Adalimumab in the Treatment of Fistulizing Crohn's Disease: A Propensity Score-Matched Analysis From the Prospective Persistence Australian National IBD Cohort (PANIC4) StudyJohn David Chetwood, Sudarshan Paramsothy, Rupert W Leong
Expert Review of Gastroenterology & Hepatology|February 23, 2019
Systematic review: the etiology of esophageal squamous cell carcinoma in low-income settingsJohn David Chetwood, Priya Garg, Peter Finch, et al.
Alimentary Pharmacology & Therapeutics|November 13, 2024
Letter: Bowel Preparation Quality in Patients With Crohn's DiseaseTamar Schildkraut, Nik John S Ding, John David Chetwood
Clinical Case Reports|August 21, 2024
Genital rash: A manifestation of metastatic Crohn's diseaseJohn David Chetwood, Arteen Arzivian, Joo-Shik Shin, et al.
Alimentary Pharmacology & Therapeutics|July 11, 2025
Meta-Analysis: Intravenous Versus Subcutaneous Infliximab in Inflammatory Bowel DiseaseJohn David Chetwood, Arteen Arzivian, Yvonne Tran, et al.
The American Journal of Gastroenterology|January 26, 2024
Biological Agents in the Treatment of Crohn's Disease: A Propensity Score-Matched Analysis From the Prospective Persistence Australian National IBD Cohort (PANIC3) StudyJohn David Chetwood, Yanna Ko, Aviv Pudipeddi, et al.
Pageof 2